Shenzhen Hepalink Pharmaceutical Group , Ltd. Inventory

The latest inventory for SHEZF is $3.9B as of June 2026. That compares with $4.7B in the prior-year period — down 16.0% year over year. Investors often review this figure alongside Shenzhen Hepalink Pharmaceutical Group , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, SHEZF's inventory moved from $4.7B to $3.9B — a 16.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Shenzhen Hepalink Pharmaceutical Group , Ltd.'s operating scale or balance-sheet position.

A inventory figure of $3.9B for SHEZF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting SHEZF's inventory ($3.9B), review year-over-year change from $4.7B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.